title: A major histocompatibility complex-peptide-restricted antibody and t cell receptor molecules recognize their target by distinct binding modes: crystal structure of human leukocyte antigen (HLA)-A1-MAGE-A1 in complex with FAB-HYB3.
abstract: Antibodies with T cell receptor-like specificity possess a considerable diagnostic and therapeutic potential, but the structural basis of the interaction between an antibody and an histocompatibility antigen has so far not been determined. We present here the crystal structure (at 2.15 A resolution) of the recombinant, affinity-matured human antibody fragment Fab-Hyb3 bound to the tumor-associated human leukocyte antigen (HLA)/peptide complex HLA-A1.MAGE-A1. Fab-Hyb3 employs a diagonal docking mode resembling that of T cell receptors. However, other than these natural ligands, the antibody uses only four of its six complementarity-determining regions for direct interactions with the target. It recognizes the C-terminal half of the MAGE-A1 peptide, the HLA-A1 alpha1-helix, and N-terminal residues of the alpha2-helix, accompanied by a large tilting angle between the two types of molecules within the complex. Interestingly, only a single hydrogen bond between a peptide side chain and Fab-Hyb3 contributes to the interaction, but large buried surface areas with pronounced shape complementarity assure high affinity and specificity for MAGE-A1. The HLA-A1.MAGE-A1.antibody structure is discussed in comparison with those of natural ligands recognizing HLA.peptide complexes.
authors.affiliation: Institut für Chemie/Kristallographie, Freie Universität Berlin, 14195 Berlin, Germany, Cellectis, 93235 Romainville, France.
authors.forename: Martin
authors.initials: M
authors.lastname: Hülsmeyer
authors.forename: Patrick
authors.initials: P
authors.lastname: Chames
authors.forename: Roman C
authors.initials: RC
authors.lastname: Hillig
authors.forename: Robyn L
authors.initials: RL
authors.lastname: Stanfield
authors.forename: Gerhard
authors.initials: G
authors.lastname: Held
authors.forename: Pierre G
authors.initials: PG
authors.lastname: Coulie
authors.forename: Claudia
authors.initials: C
authors.lastname: Alings
authors.forename: Gabriele
authors.initials: G
authors.lastname: Wille
authors.forename: Wolfram
authors.initials: W
authors.lastname: Saenger
authors.forename: Barbara
authors.initials: B
authors.lastname: Uchanska-Ziegler
authors.forename: Hennie R
authors.initials: HR
authors.lastname: Hoogenboom
authors.forename: Andreas
authors.initials: A
authors.lastname: Ziegler
mesh_terms: D000595:Amino Acid Sequence; D000951:Antigens, Neoplasm; D018360:Crystallography, X-Ray; D015788:HLA-A1 Antigen / Q000737:chemistry*; D006801:Humans; D006860:Hydrogen Bonding; D007140:Immunoglobulin Fab Fragments / Q000737:chemistry*; D008024:Ligands; D008285:Major Histocompatibility Complex; D058950:Melanoma-Specific Antigens; D008958:Models, Molecular; D008969:Molecular Sequence Data; D009363:Neoplasm Proteins / Q000737:chemistry*; D010455:Peptides / Q000737:chemistry*; D011485:Protein Binding; D011487:Protein Conformation; D017433:Protein Structure, Secondary; D017434:Protein Structure, Tertiary; D011948:Receptors, Antigen, T-Cell / Q000378:metabolism*; D014867:Water / Q000737:chemistry
chemical_list: D000951:Antigens, Neoplasm; D015788:HLA-A1 Antigen; D007140:Immunoglobulin Fab Fragments; D008024:Ligands; D058950:Melanoma-Specific Antigens; D009363:Neoplasm Proteins; D010455:Peptides; D011948:Receptors, Antigen, T-Cell; D014867:Water